CSIMarket
 
Globus Medical Inc   (GMED)
Other Ticker:  
 
 
Price: $69.9700 $0.22 0.315%
Day's High: $70.67 Week Perf: 0.85 %
Day's Low: $ 69.67 30 Day Perf: 1.72 %
Volume (M): 674 52 Wk High: $ 74.21
Volume (M$): $ 47,153 52 Wk Avg: $57.55
Open: $70.01 52 Wk Low: $43.39



 Market Capitalization (Millions $) 9,584
 Shares Outstanding (Millions) 137
 Employees 3,700
 Revenues (TTM) (Millions $) 2,237
 Net Income (TTM) (Millions $) 41
 Cash Flow (TTM) (Millions $) 104
 Capital Exp. (TTM) (Millions $) 101

Globus Medical Inc
Globus Medical Inc. is a medical device company that develops, manufactures, and markets musculoskeletal implants and surgical products. The company's products are designed for patients suffering from conditions such as spinal disorders, trauma, and joint instability. Globus Medical's product portfolio includes devices for spinal fusion, motion preservation, vertebral compression fracture treatment, and orthopedic trauma.

The company was founded in 2003 by David Paul, a former lawyer who had also worked in the medical device industry. He partnered with his brother, a surgeon, and together they set out to create a company that would revolutionize the field of musculoskeletal care. Since then, the company has grown rapidly, becoming one of the most successful medical device companies in the world.

Globus Medical operates in over 25 countries worldwide, with a strong presence in the United States, Europe, and Asia. The company's headquarters is located in Audubon, Pennsylvania, where it employs approximately 2,500 people. The company also has several manufacturing facilities located in the United States and Europe.

Globus Medical's product portfolio includes more than 160 products across four categories: spine, trauma, Orthobiologics, and joint replacement. The company's spine products comprise of implants and devices that treat conditions such as spinal stenosis, herniated discs, and scoliosis. The company's trauma products include systems that provide treatment for fractures and other injuries. The company's Orthobiologics segment covers various solutions for bone and soft tissue healing. The joint replacement segment provides implants for various joints, including the hip, knee, shoulder, and elbow.

Globus Medical's dedication to research and development has been one of the driving forces behind its success. The company invests heavily in developing innovative products and technologies that improve patient outcomes and reduce healthcare costs. The company has a team of more than 300 engineers and researchers who work to create new products and improve existing ones. Moreover, the company has over 470 patents to its name, reflecting the organization's focus on innovation.

Since going public in 2012, Globus Medical has experienced tremendous growth. The company's revenue has increased from $419 million in 2012 to a whooping $857 million in 2019. The company's commitment to delivering high-quality products and services has earned it numerous industry accolades, including being named one of the fastest-growing companies in the United States in recent times.

In conclusion, Globus Medical Inc is a leading medical device company that has revolutionized the field of musculoskeletal care. The company's strong focus on research and development, combined with its commitment to improving patient outcomes have made it one of the most successful and recognized players in the medical device industry. With its portfolio of innovative products, extensive global reach, and dedicated workforce, the company is poised to continue its growth and dominance in the coming years.


   Company Address: 2560 General Armistead Avenue Audubon 19403 PA
   Company Phone Number: 930-1800   Stock Exchange / Ticker: NYSE GMED


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

A New Epoch in Medical Innovation Globus Medical Inc. Unveils the ADIRA XLIF Plate System Amidst Financial Variances,...

Published Wed, Aug 21 2024 8:15 PM UTC

Globus Medical Heralds New Dawn with ADIRA XLIF Plate SystemIn an age where the boundaries of scientific and medical ingenuity seem ever-expansive, it is with great anticipation and fanfare that we herald the advent of Globus Medical Inc.'s latest innovation??the ADIRA XLIF Plate System. The esteemed establishment, a paragon in the realm of musculoskeletal solutions, announ...

Product Service News

Globus Medical Boosts Total Knee Arthroplasty with FDA Clearance for ExcelsiusFlex and ACTIFY 3D Total Knee S...

Published Wed, Jul 17 2024 12:30 PM UTC

Globus Medical, a prominent company specializing in musculoskeletal solutions, has recently achieved a significant milestone in enhancing surgical precision and flexibility. The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Globus Medical's ExcelsiusFlex robotic navigation platform, specifically for Total Knee Arthroplasty (TKA) application. This cu...

Globus Medical Inc

Globus Medical Inc Reports Impressive Revenue Growth, but slips into Loss in Q1 2024

Globus Medical Inc, a leading musculoskeletal solutions company, reported a significant increase in revenue for the first quarter of 2024. Despite this impressive growth, the company slipped into a loss for the period. The company announced a revenue rise of 119.26% year on year, reaching $606.67 million in the January to March 31 2024 span. This growth outpaced that of many of its industry peers, who experienced an average business rise of 6.11% during the same period.
However, Globus Medical Inc saw a decrease in earnings per share (EPS) from $0.10 per share to a loss of $0.05 per share. Revenue also decreased by -1.601% from the previous year. The company reported a net loss of $7.117 million for the period, compared to a profit of $49.129 million in the same period last year. Operating earnings fell by -85.82% to $7.997 million, leading to a significant decrease in operating margin from 20.39% to 1.32%.

Globus Medical Inc

GMED's Revenue Skyrockets, but EPS Takes a Hit in Q4 2023

Globus Medical, Inc. has had an impressive financial performance in the fourth quarter and year ended December 31, 2023. The company reported a significant revenue improvement of 124.604% year on year, reaching $616.53 million in the fourth quarter of 2023. While the income fell sharply at $0.10, this was still a notable improvement compared to the previous year.
Globus Medical Inc's revenue growth outpaced that of its industry peers in the Medical Equipment & Supplies sector, with an average revenue improvement of 5.58% in the fourth quarter of 2023 compared to the same period a year ago. Earnings per share also saw a remarkable increase of 881.81% from the previous reporting period, with revenue surging by 60.707%.

Globus Medical Inc

GMED's Spectacular Display: Unprecedented Behavior Takes Investors by Storm in Q3 2023

Financial News Report: Globus Medical Inc Reports Lower Earnings but Strong Revenue Growth
Globus Medical Inc (GMED), a leading Medical Equipment & Supplies company, recently announced its financial results for the fiscal period ending September 30, 2023. While the company experienced a significant decline in earnings per share (EPS), it recorded a considerable increase in revenue.
In the third quarter of 2023, GMED reported an EPS of $0.01, much lower than the $0.47 EPS earned in the same period last year. However, the company's revenue rose by an impressive 50.951% compared to the corresponding period, reaching $291.62 million.







Globus Medical Inc's Segments
United States    79.32 % of total Revenue
International    20.68 % of total Revenue

  Globus Medical Inc Outlook

On January 10 2024 the Globus Medical Inc provided following guidance

Globus Medical, Inc., a renowned company in musculoskel...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com